Cataracts: Natural Prevention
How diet, antioxidants, sunglasses, and lifestyle choices can delay the onset of age-related cataracts.
Cataracts cloud the lens of your eye — the clear disc that focuses light onto your retina. By age 75, roughly half of all adults have significant lens clouding, and surgery to replace the lens is the most commonly performed operation worldwide. But cataracts develop gradually over decades, and the evidence is clear that diet and lifestyle choices can meaningfully delay when they appear. A diet rich in lutein, zeaxanthin, and vitamin C, combined with not smoking and protecting your eyes from UV light, offers the most reliable natural defence. [1][2][3][4]
How Cataracts Form
The lens is made almost entirely of crystallin proteins packed so precisely that light passes through without scattering. Damage those proteins — through oxidative stress, UV radiation, or the protein-glycating effects of high blood sugar — and they begin to clump, turning the lens opaque. The lens has its own antioxidant defence system: it concentrates vitamin C to levels roughly twenty times higher than blood plasma, and it accumulates two carotenoids — lutein and zeaxanthin — that act as a molecular sunscreen. When those defences are overwhelmed or depleted over years, cataracts begin to form.
The three most common types behave differently:
- Nuclear cataracts form in the centre of the lens and are the most common age-related type — closely linked to smoking and low dietary carotenoid intake.
- Cortical cataracts develop as spoke-like opacities in the outer cortex and are strongly associated with UV exposure and diabetes.
- Posterior subcapsular cataracts form at the back of the lens and progress fastest; they are associated with steroid use, diabetes, and high myopia.
Lutein and Zeaxanthin: The Lens Carotenoids
Lutein and zeaxanthin are the only carotenoids found in the human lens (they also concentrate in the macula). They absorb blue and near-UV light before it can trigger photochemical damage to lens proteins. Both carotenoids come from food — dark leafy greens (kale, spinach, collards), egg yolks, and orange peppers are the best sources.
A 2014 meta-analysis of six prospective cohort studies found that each 10 mg/day increase in dietary lutein and zeaxanthin was associated with a 19% lower risk of age-related cataract, with the strongest effect on nuclear cataracts [2]. The large AREDS2 clinical trial then tested supplementation (10 mg lutein + 2 mg zeaxanthin daily) in 4,203 participants. On average there was no significant benefit from supplementation — but for those in the lowest fifth of habitual dietary intake, the supplement reduced cataract surgery risk by 32% [1]. The takeaway: if your diet is already rich in leafy greens, a supplement adds little; if your intake is low, it may help significantly.
Vitamin C and the Lens
The lens actively pumps vitamin C from the bloodstream to maintain internal concentrations around twenty times higher than plasma. This high local concentration allows ascorbate to act as a first-line antioxidant, neutralising free radicals generated by light before they can oxidise lens proteins. When vitamin C status is low — as it often is in smokers and in people eating few fresh fruits and vegetables — the lens loses a critical layer of protection.
A Japanese prospective study following 35,186 participants for five years found that people in the highest quintile of dietary vitamin C intake had 35-41% lower odds of developing cataracts compared to those in the lowest quintile, with consistent effects in both men and women [3]. Whole food sources — citrus, kiwi, bell peppers, strawberries, broccoli — appear to be more effective than isolated supplements, possibly because they provide co-factors and related antioxidants alongside vitamin C.
Smoking: The Biggest Modifiable Risk Factor
Cigarette smoke is one of the most potent cataractogenic exposures identified in human studies. It depletes the lens of vitamin C and glutathione, delivers cadmium (which accumulates in lens tissue), and generates a sustained oxidative load that progressively damages crystallin proteins. A meta-analysis of 21 studies — 13 prospective cohorts and 8 case-control studies — found that ever-smokers had 41-57% higher cataract risk than non-smokers [4]. Nuclear cataracts showed the strongest association (pooled OR 1.66). Importantly, ex-smokers had lower risk than current smokers, indicating that quitting smoking reduces ongoing risk — the earlier the better.
UV Protection
Ultraviolet radiation (especially UV-B) directly damages lens proteins and lipids through photochemical reactions. Epidemiological studies have linked high lifetime UV-B exposure to earlier onset of both nuclear and cortical cataracts. The prevention is straightforward: wear sunglasses that block UV to 400 nm (UV400) when outdoors, especially near water, snow, or at high altitude where UV intensity increases. Wraparound styles reduce peripheral UV exposure. A wide-brimmed hat reduces UV reaching the eye by roughly 50% on its own and complements sunglasses well.
Blood Sugar and Metabolic Health
Diabetes approximately doubles cataract risk and causes cataracts to form 10-15 years earlier than in people without diabetes. Elevated blood glucose drives two lens-damaging pathways: the accumulation of sorbitol through the polyol pathway (which draws water into the lens, disrupting fibre organisation), and the formation of advanced glycation end-products (AGEs) that crosslink crystallin proteins irreversibly. Managing blood sugar through diet — reducing refined carbohydrates, prioritising fibre-rich whole foods, maintaining a healthy weight — is one of the most important cataract prevention strategies for anyone with prediabetes or metabolic risk.
N-Acetylcarnosine Eye Drops: Not Yet Proven
N-acetylcarnosine (NAC) eye drops have generated interest as a potential way to slow or partially reverse early lens clouding. NAC acts as a prodrug, delivering carnosine into the lens where it may protect against protein carbonylation. Early clinical trials from one research group reported improvements in visual acuity and lens clarity. However, a 2017 Cochrane systematic review found no convincing evidence that NAC drops prevent cataract progression or improve vision [5]. Available trials were small and assessed as high risk of bias. These drops are available over-the-counter but cannot yet be recommended as an evidence-based intervention.
See our Eye Health: Protecting Your Vision page for related coverage of lutein, zeaxanthin, and screen habits.
Evidence Review
AREDS2: Supplemental Lutein/Zeaxanthin in an RCT
Chew et al. [1] conducted the AREDS2 study, a multicenter, double-masked randomised controlled trial of 4,203 participants aged 50-85 years. Participants were randomised in a 2x2 factorial design to lutein/zeaxanthin (10 mg/2 mg daily), omega-3 fatty acids, their combination, or placebo, with median follow-up of 4.7 years. Among the 3,159 phakic participants, 1,389 eyes underwent cataract surgery during the study. For lutein/zeaxanthin versus no lutein/zeaxanthin, the hazard ratio for cataract surgery was 0.96 (95% CI 0.84-1.10; p=0.54) — no statistically significant overall effect. However, the pre-specified subgroup of participants in the lowest quintile of baseline dietary lutein/zeaxanthin intake showed a hazard ratio of 0.68 (95% CI 0.48-0.96; p=0.03), representing a 32% risk reduction. This finding is consistent with a ceiling effect: supplementation benefits those with low baseline dietary intake but offers little additional protection to those already consuming adequate amounts from food.
Dietary Lutein/Zeaxanthin: Dose-Response Evidence
Ma et al. [2] performed a dose-response meta-analysis of six prospective cohort studies with 4,416 cataract cases among 41,999 participants. Dietary lutein and zeaxanthin intake was inversely associated with age-related cataract risk in a dose-response fashion. Each 10 mg/day increment was associated with a 19% lower cataract risk; the association was strongest for nuclear cataract and reached statistical significance across the dose range studied. This observational evidence is mechanistically coherent given the known photostabilising role of lens carotenoids and provides the biological rationale for the AREDS2 supplementation findings.
Dietary Vitamin C: The JPHC Prospective Study
Yoshida et al. [3] followed 16,415 men and 18,771 women aged 45-64 from the Japan Public Health Center-based Prospective Study for five years. At follow-up, 216 men and 551 women reported new cataract diagnoses, and 110 men and 187 women reported extractions. After adjusting for age, smoking status, alcohol intake, physical activity, body mass index, and total energy intake, participants in the highest quintile of dietary vitamin C intake had significantly reduced cataract incidence: multivariate OR 0.65 (95% CI 0.42-0.97) for men and 0.59 (95% CI 0.43-0.89) for women. Effects were in the same direction for cataract extraction. The study is notable for its size and prospective design, and for being conducted in a non-supplement-using Asian population where dietary variation is the primary source of vitamin C differences.
Smoking as a Quantified Hazard
Ye et al. [4] synthesised 13 prospective cohort studies and 8 case-control studies examining the relationship between smoking and age-related cataract. In cohort studies, ever-smoking was associated with OR 1.41 (95% CI 1.23-1.62). In case-control studies, OR was 1.57 (95% CI 1.20-2.07). Nuclear cataracts showed the strongest association: summary OR 1.66 (95% CI 1.46-1.89). No statistically significant association was found between smoking and cortical cataracts. Current smokers were at higher risk than past smokers, and some studies reported dose-dependent effects with pack-years. The proposed mechanism involves both direct oxidative stress from cigarette smoke compounds and depletion of lens antioxidants including vitamin C, glutathione, and superoxide dismutase. Heavy metals in smoke — particularly cadmium — also accumulate in the lens over years.
N-Acetylcarnosine Drops: Cochrane Assessment
Dubois and Bastawrous [5] conducted a Cochrane systematic review of randomised controlled trials of NAC eye drops for age-related cataract. The review identified trials primarily from one research group (Babizhayev and colleagues) and assessed them as having unclear or high risk of bias. The review concluded there is currently no convincing evidence that NAC drops either reverse cataract or prevent its progression, and that the available evidence was insufficient to evaluate safety and tolerability adequately. The biological rationale for carnosine as a lens antioxidant and transglycating agent is plausible — carnosine can inhibit protein carbonylation and cross-linking — but this has not translated into proven clinical benefit in well-designed, independently conducted trials. NAC drops remain an area of active interest but are not yet ready for evidence-based recommendation.
Overall Assessment
The evidence picture for cataract prevention is unusually coherent across dietary and lifestyle domains. Lutein/zeaxanthin and vitamin C from food have consistent epidemiological support, plausible biological mechanisms, and are free of harm. Not smoking is the most impactful single intervention, with risk roughly halving within years of cessation based on available data. UV protection and blood sugar management are important secondary factors. The overall quality of evidence is moderate — most nutritional data comes from observational cohorts — but the consistency across populations and mechanistic plausibility provides reasonable confidence in the dietary recommendations.
References
- Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4Chew EY, SanGiovanni JP, Ferris FL, et al.; Age-Related Eye Disease Study 2 Research Group. JAMA Ophthalmol, 2013. PubMed 23645227 →
- A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataractMa L, Hao ZX, Liu RR, Yu RB, Shi Q, Pan JP. Graefes Arch Clin Exp Ophthalmol, 2014. PubMed 24150707 →
- Prospective study showing that dietary vitamin C reduced the risk of age-related cataracts in a middle-aged Japanese populationYoshida M, Takashima Y, Inoue M, Iwasaki M, Otani T, Sasaki S, Tsugane S; JPHC Study Group. Eur J Nutr, 2007. PubMed 17265171 →
- Smoking and risk of age-related cataract: a meta-analysisYe J, He J, Wang C, Wu H, Shi X, Zhang H, Xie J, Lee SY. Invest Ophthalmol Vis Sci, 2012. PubMed 22599585 →
- N-acetylcarnosine (NAC) drops for age-related cataractDubois VD, Bastawrous A. Cochrane Database Syst Rev, 2017. PubMed 28245346 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.